BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11680658)

  • 1. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
    Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J; Kryński J
    Pediatr Pol; 1995 Dec; 70(12):1037-42. PubMed ID: 8649943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF; Brodeh J
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO; Kari JA
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.
    Aksu N; Türker M; Erdoğan H; Ozinel S; Kansoy S
    Turk J Pediatr; 1999; 41(2):225-30. PubMed ID: 10770662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P; Bianchetti MG; Imoberdorf G; Lütschg J; Reymond D; Oetliker OH
    Schweiz Med Wochenschr; 1994 May; 124(19):801-5. PubMed ID: 8209202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F; Ahmed TM; Samina U
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
    Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R; Brem AS
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Srivastava RN; Agarwal RK; Choudhry VP; Moudgil A; Bhuyan UN; Sunderam KR
    Int J Pediatr Nephrol; 1985; 6(4):245-50. PubMed ID: 4093243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S; Mahalingam V; Nageswaran P; Udani A; Geminiganesan S; Priyadarshini S
    Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS; Shien CY; Chi CS
    Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.